These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6281621)

  • 1. Preparation and properties of human C1 inhibitor.
    Sim RB; Reboul A
    Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
    Nilsson T; Wiman B
    Eur J Biochem; 1983 Jan; 129(3):663-7. PubMed ID: 6297891
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and activation of C1: current concepts.
    Colomb MG; Arlaud GJ; Villiers CL
    Complement; 1984; 1(2):69-80. PubMed ID: 6100485
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 13. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease.
    Loos M; Colomb M
    Behring Inst Mitt; 1993 Dec; (93):1-5. PubMed ID: 8172555
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical hypocomplementemic vasculitis syndrome in a child.
    Waldo FB; Leist PA; Strife CF; Forristal J; West CD
    J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.